Cargando…
Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancer
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Despite the successful application of immune checkpoint blockade in a range of human cancers, immunotherapy in PDAC remains unsuccessful. PDAC is characterized by a desmoplastic, hypoxic and highly immunosuppressive...
Autores principales: | Boelaars, Kelly, Goossens-Kruijssen, Laura, Wang, Di, de Winde, Charlotte M, Rodriguez, Ernesto, Lindijer, Dimitri, Springer, Babet, van der Haar Àvila, Irene, de Haas, Aram, Wehry, Laetitia, Boon, Louis, Mebius, Reina E, van Montfoort, Nadine, Wuhrer, Manfred, den Haan, Joke M M, van Vliet, Sandra J, van Kooyk, Yvette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632901/ https://www.ncbi.nlm.nih.gov/pubmed/37940346 http://dx.doi.org/10.1136/jitc-2023-007805 |
Ejemplares similares
-
Disruption of sialic acid metabolism drives tumor growth by augmenting CD8(+) T cell apoptosis
por: Cornelissen, Lenneke A.M., et al.
Publicado: (2019) -
Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021) -
Immune involvement of the contralateral hemisphere in a glioblastoma mouse model
por: Crommentuijn, Matheus H W, et al.
Publicado: (2020) -
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
por: Lübbers, Joyce, et al.
Publicado: (2018) -
Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy
por: Schetters, Sjoerd T T, et al.
Publicado: (2020)